Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Acta Physiologica Sinica ; (6): 565-570, 2003.
Article Dans Chinois | WPRIM | ID: wpr-290926

Résumé

Gerbil forebrain ischemia/reperfusion(I/R) injury model was used to study the effects of D(1) and D(2) receptor agonists and antagonists on neuronal apoptosis of hippocampal CA1 area. All animals were tested for habituation deficits in an open field test on the 1st, 3rd and 7th days after reperfusion. The animals were then killed, and brains underwent paraffin embedding for hematoxylin-eosin staining, in situ terminal deoxynucleotidyl transferase-mediated deoxy-UTP nick end labeling (TUNEL) staining and immunohistochemistry (bax, bcl-2). The result of open field test showed that the I/R group was significantly impaired (higher activity scores) when compared with the control group. Pretreatment with pergolide significantly reduced this habituation impairment. Forebrain ischemia for 5 min resulted in extensive CA1 apoptosis on the 3rd and 7th days after I/R injury. About 95% neurons in hippocampal CA1 area entered apoptosis and only 2%-7% pyramidal neurons stayed alive due to an inhibition of bcl-2 expression and an increase in bax expression. Pretreatment of pergolide attenuated neuronal damage caused by transient ischemia. Infusion of pergolide could induce the expression of bcl-2 and reduce the expression of bax. Pretreatment with SKF38393, SCH23390 and spiperone had no effects on these changes in this transient I/R injury model. All these results indicate that pergolide plays an important role in the protection of hippocampal neurons from apotosis through upregulating the expression of bcl-2 protein and reducing the expression of bax protein.


Sujets)
Animaux , Mâle , 1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol , Pharmacologie , Apoptose , Encéphale , Encéphalopathie ischémique , Agonistes de la dopamine , Pharmacologie , Antagonistes de la dopamine , Pharmacologie , Gerbillinae , Hippocampe , Accident ischémique transitoire , Neurones , Physiologie , Neuroprotecteurs , Pharmacologie , Pergolide , Pharmacologie , Prosencéphale , Protéines proto-oncogènes , Génétique , Protéines proto-oncogènes c-bcl-2 , Génétique , Récepteur dopamine D1 , Récepteur D2 de la dopamine , Lésion d'ischémie-reperfusion , Protéine Bax
SÉLECTION CITATIONS
Détails de la recherche